Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariusz Bidzinski

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Gynecologic Oncology|November 20, 2009
The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinomaJakub Radziszewski, Magdalena Kowalewska, Tomasz Jedrzejczak, et al.
BMC Cancer|June 8, 2012
Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodesMagdalena Kowalewska, Jakub Radziszewski, Krzysztof Goryca, et al.
Ginekologia Polska|January 28, 2026
Systemic recommendations on the promotion of HPV vaccinations based on international social marketing campaignsKatarzyna Bochniak, Aneta Nitsch-Osuch, Juan Diego Zamudio Padilla, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 6, 2010
Clinical significance of serum CA-125 and soluble tumor necrosis factor receptor type I in cervical adenocarcinoma patientsBeata Kotowicz, Janina Kaminska, Malgorzata Fuksiewicz, et al.
Cancer Genetics|April 4, 2012
High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associationsIwona K Rzepecka, Lukasz Szafron, Agnieszka Stys, et al.
Journal of Clinical Medicine|February 25, 2023
The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma (2023)Jacek J Sznurkowski, Janusz Rys, Artur Kowalik, et al.
Ginekologia Polska|September 22, 2022
Recommendations of the Polish Society of Gynaecologists and Obstetricians, Polish Paediatric Society, Polish Society of Family Medicine, Polish Society of Vaccinology, Polish Society of Oncological Gynaecology and Polish Society of Colposcopy and Pathophysiology of the Uterine Cervix on prophylactic vaccinations against infections with human papillomaviruses in PolandAndrzej Nowakowski, Robert Jach, Leszek Szenborn, et al.
Gynecologic Oncology|March 4, 2008
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survivalDavid S Alberts, Christian Marth, Ronald D Alvarez, et al.
Ebiomedicine|August 31, 2019
Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progressionDonata Ponikwicka-Tyszko, Marcin Chrusciel, Joanna Stelmaszewska, et al.
Gynecologic Oncology|January 21, 2020
Second-line lenvatinib in patients with recurrent endometrial cancerIgnace Vergote, Matthew A Powell, Michael G Teneriello, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Gynecologic Oncology|November 20, 2009
The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinomaJakub Radziszewski, Magdalena Kowalewska, Tomasz Jedrzejczak, et al.
BMC Cancer|June 8, 2012
Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodesMagdalena Kowalewska, Jakub Radziszewski, Krzysztof Goryca, et al.
Ginekologia Polska|January 28, 2026
Systemic recommendations on the promotion of HPV vaccinations based on international social marketing campaignsKatarzyna Bochniak, Aneta Nitsch-Osuch, Juan Diego Zamudio Padilla, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 6, 2010
Clinical significance of serum CA-125 and soluble tumor necrosis factor receptor type I in cervical adenocarcinoma patientsBeata Kotowicz, Janina Kaminska, Malgorzata Fuksiewicz, et al.
Cancer Genetics|April 4, 2012
High frequency of allelic loss at the BRCA1 locus in ovarian cancers: clinicopathologic and molecular associationsIwona K Rzepecka, Lukasz Szafron, Agnieszka Stys, et al.
Journal of Clinical Medicine|February 25, 2023
The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Endometrial Carcinoma (2023)Jacek J Sznurkowski, Janusz Rys, Artur Kowalik, et al.
Ginekologia Polska|September 22, 2022
Recommendations of the Polish Society of Gynaecologists and Obstetricians, Polish Paediatric Society, Polish Society of Family Medicine, Polish Society of Vaccinology, Polish Society of Oncological Gynaecology and Polish Society of Colposcopy and Pathophysiology of the Uterine Cervix on prophylactic vaccinations against infections with human papillomaviruses in PolandAndrzej Nowakowski, Robert Jach, Leszek Szenborn, et al.
Gynecologic Oncology|March 4, 2008
Randomized phase 3 trial of interferon gamma-1b plus standard carboplatin/paclitaxel versus carboplatin/paclitaxel alone for first-line treatment of advanced ovarian and primary peritoneal carcinomas: results from a prospectively designed analysis of progression-free survivalDavid S Alberts, Christian Marth, Ronald D Alvarez, et al.
Ebiomedicine|August 31, 2019
Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progressionDonata Ponikwicka-Tyszko, Marcin Chrusciel, Joanna Stelmaszewska, et al.
Gynecologic Oncology|January 21, 2020
Second-line lenvatinib in patients with recurrent endometrial cancerIgnace Vergote, Matthew A Powell, Michael G Teneriello, et al.
Pageof 5